Stock search

Ticker or company name

Cardinal Health

CAH · NYSE · Health Care

$283,85Up +2,75 (+0,98%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$65,0 bn
Div. yield
1,9%
Year to date
+36,8%
52 weeks: $180,45$286,29

Ratio score

Not enough data for a score

The score is calculated when at least 6 of 10 metrics are known.

Key metrics

1 ✓ · 0 — · 2 ✕ · 7 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM35,727,725,1
Forward P/E19,2—16,2
PEG3,1—2,2
P/S0,30,12,2
EV/EBITDA23,219,817,3
P/FCF13,3—19,5
P/B65,15,93,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 22 analysts

Buy
19
Hold
3
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q1 20272,973,26Up +9,8%
Q4 20262,442,60Up +6,4%
Q3 20262,823,17Up +12,6%
Q2 20262,402,63Up +9,4%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue67,5 bn65,6 bn64,0 bn60,2 bn54,9 bn55,3 bn52,3 bn59,7 bn54,9 bn57,4 bn54,8 bn53,5 bn
EPS2,38—1,88———1,70—1,071,500,02—
Margin0,8%0,7%0,7%0,4%0,9%0,7%0,8%0,4%0,5%0,6%0,0%−0,1%
FCF1,24 bn555 m865 m1,30 bn2,79 bn−499 m−1,74 bn1,88 bn−161 m1,08 bn453 m641 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $61,6 m.

NameAmountSharesPrice
scherer mary c.19 Aug 2026 · sale$522 7332 202$237,39
scherer mary c.19 Aug 2026 · sale$23 740100$237,40
hollar jason m.19 Aug 2026 · sale$1,49 m6 244$237,88
hollar jason m.19 Aug 2026 · sale$3,84 m16 187$237,23
hollar jason m.19 Aug 2026 · sale$1,59 m6 731$236,46
hollar jason m.19 Aug 2026 · sale$1,34 m5 704$235,34
hollar jason m.19 Aug 2026 · sale$809 9413 457$234,29
hollar jason m.19 Aug 2026 · sale$1,45 m6 206$233,22
greene michelle d.18 Aug 2026 · sale$162 754686$237,25
greene michelle d.18 Aug 2026 · sale$829 9213 512$236,31
greene michelle d.18 Aug 2026 · sale$1,17 m4 952$235,68
greene michelle d.18 Aug 2026 · sale$586 4252 500$234,57
weitzman deborah18 Aug 2026 · sale$66 721281$237,44
weitzman deborah18 Aug 2026 · sale$96 529408$236,59
weitzman deborah18 Aug 2026 · sale$1,57 m6 665$235,30

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
4 Aug 1983

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
BSXBoston Scientific$43,6983would consider18,4+8,9%16,6%
CORCencora$356,9483would consider19,7+5,1%0,8%
EWEdwards Lifesciences$107,1156would watch60,3+13,4%15,2%
BDXBecton Dickinson$216,4738would not consider51,8−2,6%4,5%
IDXXIdexx Laboratories$700,6583would consider47,2+11,9%25,4%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.